Multicenter Clinical Evaluation of the (1->3) -D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Measurement of (1-->3)-beta-D-Glucan (BG) has emerged as an adjunct diagnostic strategy for invasive fungal infections (IFI). METHODS: Subjects at 6 clinical sites in the United States were enrolled as either fungal infection-negative subjects (n = 170) or subjects with proven or probable IFI according to European Organization for the Research and Treatment of Cancer/Mycoses Study Group criteria (n = 163). A central laboratory and 4 sites performed assays. A single sample was obtained per patient and was evaluated using an assay to detect serum BG derived from fungal cell walls (range, 0 to > 7000 pg/mL). RESULTS: At a cutoff of 60 pg/mL, the sensitivity and specificity of the assay were 69.9% and 87.1%, respectively, with a positive predictive value (PPV) of 83.8% and a negative predictive value (NPV) of 75.1%. At a cutoff value of 80 pg/mL, the sensitivity and specificity were 64.4% and 92.4%, respectively, with a PPV of 89% and an NPV of 73%. Of the 107 patients with proven candidiasis, 81.3% had positive results at a cutoff value of 60 pg/mL, and 77.6% had positive results at a cutoff value of 80 pg/mL. Of the 10 patients with aspergillosis, 80% had positive results at cutoff values of 60 and 80 pg/mL. The 3 subjects diagnosed with Fusarium species had positive results at a cutoff value of 60 pg/mL. Patients infected with Mucor or Rhizopus species (both of which lack BG) had negative results at both cutoff values, and of the 12 patients with Cryptococcus infection, 3 had positive results at a cutoff value of 60 pg/mL, and 2 had positive results at a cutoff value of 80 pg/mL. Of the subjects with proven positive results who were receiving antifungal therapy (n = 118), 72.9% had results positive for BG at a cutoff value of 60 pg/mL, and 69.5% had results positive for BG at a cutoff value of 80 pg/mL. The interlaboratory sample test r2 was 0.93. CONCLUSION: Reproducible assay results with high specificity and high PPV in a multicenter setting demonstrate that use of an assay to detect serum BG derived from fungal cell walls is a useful diagnostic adjunct for IFI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sensitivity and specificity have been estimated to be 69.9 and 87.1%, respectively [47], as there are a high number of false positive results.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [47]
In the citing paper
“(1 ?3)-b-D-glucan is a component of the cell wall of many fungi and has been proposed as a non-specific marker for invasive fungal infections.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [47]
In the citing paper
“b-1, 3-D-Glucan detection has also been evaluated in critically ill patients, with sensitivity and specificity for diagnosis of IC estimated to be 69.9% and 87.1%, respectively.63”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [63]
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331 · cited 3×
“Subjects. Subjects without IFI and subjects with proven or probable IFI (determined according to the European Organization for the Research and Treatment of Cancer/Mycoses Study Group [EORTC/MSG] criteria [ 15 ]) from 6 clinical sites in the United States consented to participate in this study, and a single blood samp…”
MethodSelf-citation(2012) · Hepatogastroenterology · doi:10.5754/hge11801 · Cited by 802
Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M. A., Rex, J. H., & Ostrosky-Zeichner, L. (2004) · Clinical Infectious Diseases · doi:10.1086/421944 · Cited by 642 · cited 4×
“The reactivity of the Fungitell assay with Pachyman standard is lower than that of the Fungitec-G assay [9].”
BackgroundMethodSelf-citationObayashi, T., Kawai, T., Yoshida, M., Mori, T., Goto, H., Yasuoka, A., Shimada, K., Iwasaki, H., Teshima, H., Kohno, S., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91152-9 · Cited by 530
Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States
Ostrosky-Zeichner, L., Rex, J. H., Pappas, P. G., Hamill, R. J., Larsen, R. A., Horowitz, H. W., Powderly, W. G., Hyslop, N., Kauffman, C. A., Cleary, J., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3149-3154.2003 · Cited by 498 · cited 1×
“parapsilosis [19].”
Self-citationThe use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis
Horvath, J. A., & Dummer, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89455-7 · Cited by 323 · cited 1×
“of cases of invasive aspergillosis [4].”
The New Fungal Opportunists Are Coming
Perfect, J. R., & Schell, W. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s112 · Cited by 224 · cited 1×
“critical care [1].”
Miyazaki, T., Kohno, S., Mitsutake, K., Maesaki, S., Tanaka, K., Ishikawa, N., & Hara, K. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.12.3115-3118.1995 · Cited by 204
Digby, J., Kalbfleisch, J. H., Glenn, A., Larsen, A. R., Browder, W., & Williams, D. L. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.5.882-885.2003 · Cited by 153 · cited 2×
“[18] observed low specificity for fungal infections in a study involving 46 subjects in intensive care units.”
BackgroundMolecular mechanism of hemolymph clotting system in Limulus
Iwanaga, S., Miyata, T., Tokunaga, F., & Muta, T. (1992) · Thrombosis Research · doi:10.1016/0049-3848(92)90124-s · Cited by 133 · cited 1×
“BG produced by fungi [6] is detected by a glucan assay on the basis of its recognition by the innate immune system of horseshoe crabs, specifically Tachypleus tridentatus and Limulus polyphemus [7].”
Background
Research works printed but not linked: 1
- Nakao, 1997, Hepato-gastroenterology, 44, 1413
Cited by
Items 401–500 of 667
Quanping, S., Huai, Y., Yicun, W., Ju, Z., Yuling, G., & Li, W. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.07.009 · Cited by 11
Single Academic Center Experience of Unrestricted β-d-Glucan Implementation
Fabre, V., Markou, T. I., DeMallie, K., Mehta, S., Shoham, S., Tamma, P. D., Zhang, S. X., & Cosgrove, S. E. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy195 · Cited by 11
“To be meaningful, however, the test must be applied in the correct setting (ie, in patients with a compatible clinical presentation and for a fungal infection that BDG can detect) [4, 5].”
BackgroundLü, X., Tang, T., Hu, C., Tian, Z., & Chen, C. (2018) · Open Medicine · doi:10.1515/med-2018-0050 · Cited by 11
Diagnostic surveillance by Candida albicans germ tube antibody in intensive care unit patients
Trovato, L., Astuto, M., Castiglione, G., Scalia, G., & Oliveri, S. M. (2019) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2019.02.001 · Cited by 12
Management of Fungal or Atypical Periprosthetic Joint Infections
Gebauer, M., Frommelt, L., Achan, P., Tim Board, Conway, J. D., Griffin, W. L., Heidari, N., Kerr, G. J., McLaren, A. C., Nelson, S. B., et al. (2014) · Journal of Orthopaedic Research® · doi:10.1002/jor.22559 · Cited by 11
“Review of the current literature did not detect a laboratory test to specifically monitor fungal PJI.”
InfluentialMétodos microbiológicos para el diagnóstico, manejo y estudio de la infección fúngica invasora
Canton, E., García‐Rodríguez, J., Martín‐Mazuelos, E., Pemán, J., & Guinea, J. (2013) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2013.01.008 · Cited by 17
“El EUCAST también ha estandarizado un método de microdilución para levaduras (documento EDef 7.1) 17 y para hongos filamentosos (documento E.DEF 9.1) .”
InfluentialKedzierska, A. E. (2007) · PubMed · Cited by 11
Ostrosky-Zeichner, L. L., Paetznick, V. L., Rodriguez, J., Chen, E., & Sheehan, D. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00955-08 · Cited by 12
Self-citationNew serological markers in medical mycology: (1,3)-(-D-glucan and Aspergillus galactomannan
Ostrosky-Zeichner, L. L., Vitale, R. G., & Nucci, M. (2012) · Infectio · doi:10.1016/s0123-9392(12)70028-0 · Cited by 12
Self-citationLahmer, T., Held, J., Rasch, S., Schnappauf, C., Beitz, A., Schmid, R. M., & Huber, W. (2016) · Mycopathologia · doi:10.1007/s11046-016-0061-0 · Cited by 12
Systemic Candidiasis: Candidemia and Deep-Organ Infections
Clancy, C. J., & Nguyen, M. H. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch27 · Cited by 15
Algal β-glucan: Structure, immunomodulatory effects and application prospects
Wang, W., Wang, J., Wu, N., Yang, Y., Geng, L., & Zhang, Q. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.124801 · Cited by 12
Invasive pulmonary aspergillosis in the ICU: the corticosteroid link
Terrones-Campos, C., Gallardo‐Pizarro, A., Martínez-Urrea, A., Castiella, A., Vergara, A., Gonzalez, A., Egri, N., & García‐Vidal, C. (2026) · Pneumonia · doi:10.1186/s41479-025-00189-5 · Cited by 13
“Serum (1 → 3)-β-D-glucan (BDG) is considered highly sensitive and specific for invasive fungal infections, and its positive and negative predictive values are comparable to those of galactomannan in the diagnosis of IPA [75, 76].”
Indian Antimicrobial Prescription Guidelines in Critically Ill Immunocompromised Patients
Rodrigues, C. S., Soman, R. N., Desai, M. M., Kulkarni, A. P., & Chinnaswamy, G. (2019) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23102 · Cited by 11
Kumar, M., JANTAUSCH, B. A., Torres, C., Campos, J. M., & Zelazny, A. M. (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix108 · Cited by 10
Invasive Fungal Infections and Approaches to Their Diagnosis
Pfaller, M. A. (2015) · Methods in microbiology · doi:10.1016/bs.mim.2015.05.002 · Cited by 13
Molecular and serological diagnosis of invasive aspergillosis: new answers to old questions?
Hummel, M., & Buchheidt, D. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01376.x · Cited by 11
Lindsley, M. D. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0146-x · Cited by 11
“The Fungitell assay is used for BDG detection in serum and has been evaluated in cases of aspergillosis [41•], candidiasis [42, 43] and most recently, infections with Pneumocystis jiroveci [44].”
MethodKaita, Y., Tarui, T., Otsu, A., Tanaka, Y., Suzuki, J., Yoshikawa, K., & Yamaguchi, Y. (2018) · Journal of Burn Care & Research · doi:10.1093/jbcr/iry055 · Cited by 12
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590225 · Cited by 17
Self-citationDiagnosis and Treatment of Fungal Infections in Lung Transplant Recipients
Escamilla, J. E., January, S. E., & Guillamet, R. V. (2023) · Pathogens · doi:10.3390/pathogens12050694 · Cited by 10
Update: invasive Pilzinfektionen: Diagnose und Therapie in der operativen Intensivmedizin
Lichtenstern, C., Swoboda, S., Hirschburger, M., Domann, E., Hoppe‐Tichy, T., Winkler, M., Lass‐Flörl, C., & Weigand, M. A. (2010) · Der Anaesthesist · Cited by 9
Marchetti, O., Eggimann, P., & Calandra, T. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e2629 · Cited by 9
General Approaches for Direct Detection and Identification of Fungi
Ashbee, H. R. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch116 · Cited by 9
Update: invasive Pilzinfektionen
Lichtenstern, C., Swoboda, S., Hirschburger, M., Domann, E., Hoppe‐Tichy, T., Winkler, M., Lass‐Flörl, C., & Weigand, M. A. (2010) · Der Anaesthesist · doi:10.1007/s00101-009-1655-4 · Cited by 12
Jung, B., Bihan, C. L., Portalès, P., Bourgeois, N., Vincent, T., Lachaud, L., Chanques, G., Conseil, M., Corne, P., Massanet, P. L., et al. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00918-1 · Cited by 11
Anderson, E. J. (2014) · Cancer treatment and research · doi:10.1007/978-3-319-04220-6_7 · Cited by 13
“False positives have also been observed with certain medications, following hemodialysis, with use of IV tubing filters, with administration of albumin or immunoglobulin, and after exposure to gauze [108, 111].”
BackgroundMorrissey, C. O., & Slavin, M. A. (2006) · Medical Mycology · doi:10.1080/13693780600826699 · Cited by 9
Pontón, J. (2006) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(06)70007-9 · Cited by 14
Simultaneous increase in 1,3-β-d-glucan and procalcitonin levels in Pseudomonas aeruginosa infection
Koya, J., Nannya, Y., Kobayashi, H., Okugawa, S., Moriya, K., & Kurokawa, M. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.03.017 · Cited by 9
Chen, Z., Jiang, Y., Wang, D., Zheng, M., Liu, X., & Yuan, C. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104703 · Cited by 8
Invasive fungal infections in hemato-oncology
Oberoi, J. K., Sheoran, L., Sagar, T., & Saxena, S. (2023) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2023.01.011 · Cited by 10
del Pozo, R. B. M., Alonso, M. R., & García, M. S. C. (2018) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2017.07.004 · Cited by 11
Disseminated coccidioidomycosis: Monitoring of serologic markers for treatment response
Wilmes, D., Schui, D., Held, J., Ackermann, S., Geipel, U., Emrich, K., Winkelmann, E.-J., & Rickerts, V. (2020) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2020.05.007 · Cited by 8
Identification of fungal trehalose for the diagnosis of invasive candidiasis by mass spectrometry
Méry, A., Jawhara, S., François, N., Cornu, M., Poissy, J., Martinez‐Esparza, M., Poulain, D., Sendid, B., & Guérardel, Y. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130083 · Cited by 9
“They are clinically recommended as useful adjuncts to blood cultures [5,6].”
BackgroundCurrent Status of Diagnosis of Mucormycosis: Update on Molecular Methods
Dannaoui, É., & Millon, L. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0196-8 · Cited by 8
Diagnostic Approach Based on Capsular Antigen, Capsule Detection, β-Glucan, and DNA Analysis
Diaz, M. R., & Nguyen, M. H. (2014) · ASM Press eBooks · doi:10.1128/9781555816858.ch41 · Cited by 8
β-d-Glucan and Aspergillus Galactomannan assays in the diagnosis of invasive fungal infections
Kumar, M., & Mugunthan, M. (2017) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2017.10.005 · Cited by 9
The laboratory and clinical mycology
Pfaller, M. A., & McGinnis, M. R. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00004-9 · Cited by 9
Biomarker-guided antifungal stewardship policies for patients with invasive candidiasis
Honarvar, B., Lankarani, K. B., Taghavi, M., Vahedi, G., & Mortaz, E. (2019) · Current Medical Mycology · doi:10.18502/cmm.4.4.385 · Cited by 8
Buchacher, A., Krause, D., Wiry, G., & Weinberger, J. (2010) · PubMed · Cited by 8
Current updates on fungal endocarditis
Negi, N., & Ahmad, A. (2017) · Fungal Biology Reviews · doi:10.1016/j.fbr.2017.11.001 · Cited by 7
Clinical Syndromes: Candida and Candidosis
Ruhnke, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-92300-0_4 · Cited by 8
Treatment of Non-Aspergillus Mold Infections: a Focus on Mucormycosis and Fusariosis
Phoompoung, P., & Luong, M. (2019) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-019-00205-5 · Cited by 8
Esteves, P., Lima, S. L., Melo, A. S. D. A., Beirão, E. M., Nucci, M., & Colombo, A. L. (2020) · Mycoses · doi:10.1111/myc.13224 · Cited by 8
“Age (years), median (range) 56 (18-87) Gender Male 44 (62) Female 27 (38) Comorbidities Cardiovascular disease 22 (30.”
BackgroundViegas, C., Twarużek, M., Dias, M., Carolino, E., Soszczyńska, E., & Caetano, L. A. (2022) · Toxins · doi:10.3390/toxins14020070 · Cited by 7
Validation of a New (1 → 3)-β-D-Glucan Test Kit, Fungitec G Test MKⅡ “ Nissui ”
Obayashi, T., Sugimoto, A., Takigawa, C., Sekiya, N., Nagasawa, J., & Ozaki, Y. (2015) · Medical Mycology Journal · doi:10.3314/mmj.56.j73 · Cited by 9
Infección fúngica invasora en el trasplante de órgano sólido
Gavaldà, J., Meije, Y., Len, Ó., & Pahissa, A. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2012.09.004 · Cited by 8
Strategy for Overcoming Serum Interferences in Detection of Serum (1,3)-β- d -Glucans
Sendid, B., François, N., Decool, V., Poissy, J., & Poulain, D. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02356-12 · Cited by 7
“The (1,3)- -D-glucan (BG) is a cell-wall polysaccharide of most fungi.”
BackgroundInfluentialPharmacotherapy of Candida Infections with Echinocandins
Espinel-Ingroff, A. V., Canton, E., Martín‐Mazuelos, E., & Pemán, J. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s2311 · Cited by 7
Viviani, M. A., & Tortorano, A. M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00009-8 · Cited by 8
Hobson, C. A., Désoubeaux, G., Carvalho-Schneider, C., Destrieux, C., Cottier, J., Garot, D., Brun, C. L., Maakaroun-Vermesse, Z., Lemaignen, A., Bailly, É., et al. (2020) · Medical Mycology · doi:10.1093/mmy/myaa035 · Cited by 8
Menkovska, M., Branković, G., Pajić, V., Šurlan-Momirović, G., & Knežević, D. (2015) · Natural Science and Discovery · doi:10.20863/nsd.44541 · Cited by 7
Issa, N. C., Koo, S., Lynch, R. C., Gay, C., Hammond, S. P., Baden, L. R., Ghobrial, I. M., Finkelman, M., & Marty, F. M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.06295-11 · Cited by 7
Self-citationAntifungal prophylaxis and treatment in patients with hematological malignancies
Hwang, Y., & Liang, R. H. S. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.16 · Cited by 7
Fusarium and Other Opportunistic Hyaline Fungi
Sutton, D. A., & Brandt, M. E. (2011) · Wiley eBooks · doi:10.1128/9781555816728.ch118 · Cited by 18
Candida auris in intensive care unit: A growing clinical concern
Bassetti, M., Magnasco, L., Lamarina, A., Paola, L. D., Vena, A., Giacobbe, D. R., & Bartalucci, C. (2025) · Journal of Translational Critical Care Medicine · doi:10.1097/jtccm-d-25-00003 · Cited by 10
Sathyapalan, D. T., Balachandran, S., Kumar, A., Rajamma, B. M., Pillai, A., & Menon, V. P. (2016) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2016.11.008 · Cited by 6
Foiling fungal disease post hematopoietic cell transplant: review of prophylactic strategies
Rubinstein, S., Culos, K. A. A., Savani, B. N., & Satyanarayana, G. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2017.222 · Cited by 6
Identification Methods – An Overview
Makarewicz, O., Stein, C., Pfister, W., Löffler, B., & Pletz, M. W. (2015) · Wiley eBooks · doi:10.1002/9783527687978.ch2 · Cited by 9
β‐Glucan in the Diagnosis of Invasive Fungal Disease
Pasqualotto, A. C., & Sukiennik, T. (2008) · Clinical Infectious Diseases · doi:10.1086/589571 · Cited by 6
Diagnostic Approaches to Invasive Candidiasis: Challenges and New Perspectives
Slepčanová, H., Dobiáš, R., Langer, A. B. S., Káňová, M., & Hamal, P. (2025) · Mycopathologia · doi:10.1007/s11046-025-01035-4 · Cited by 5
The emerging pathogen Candida auris: host interactions and disease drivers
Sanya, D. R. A., Arevalo, A. V., Onésime, D., & Nobile, C. J. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01230-5 · Cited by 6
Ashraf, S., Biglow, L. R., Dotson, J., & Tirona, M. T. (2021) · Translational Breast Cancer Research · doi:10.21037/tbcr-21-19 · Cited by 5
“Beta-D-glucan was elevated at 250 pg/mL, which may suggest underlying fungal infections such as candidiasis and aspergillosis, but the specificity of this assay is limited with a high false positive rate (7).”
BackgroundFarina, C., Lombardi, G., Andreoni, S., Manso, E., Perin, S., Panellis, D., Fazii, P., Conte, M., Sanna, S., Pini, P., et al. (2014) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201402700424 · Cited by 6
“In order to overcome such limitations, several non-culture based methods have been set up, thus allowing detection offungal DNA (710), fungal antigens/metabolites (11-14) or antifungal antibodies as specific markers of infection (15).”
BackgroundMikulska, M., Furfaro, E., & Viscoli, C. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0101-2 · Cited by 6
“Another problematic issue might be BG performance in different fungal infections, because the available studies usually reported data for all various fungal infections [16].”
BackgroundResultMoosig, F., Reinhold‐Keller, E., Holl‐Ulrich, K., Feller, A. C., Bley, T. A., Holle, J. U., Zwerina, J., Lamprecht, P., Dalhoff, K., Venhoff, N., et al. (2012) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-012-0988-6 · Cited by 7
Pemán, J., & Almirante, B. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13128779 · Cited by 10
Hematogenously disseminated fungal infections
Baer, S. L., & Pappas, P. G. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00029-3 · Cited by 6
Self-citationFatal pulmonary infection with respiratory syncytial virus in an immunocompromised adult patient
Wang, Q., Li, W., Qu, D., Tong, X., & Gao, P. (2018) · Medicine · doi:10.1097/md.0000000000011528 · Cited by 5
“Fungal pneumonia is increasingly common, particularly in highly immunosuppressed patients, and the measurement of serum (1→3)-b-D-glucan level has emerged as an adjunct method for the diagnosis of invasive fungal infections.([13,14]) In the present case report, the patient presented with elevated (1→3)-b-Dglucan level…”
BackgroundNeofytos, D., Steinbach, W. J., Hanson, K. E., Carpenter, P. A., Papanicolaou, G. A., & Slavin, M. A. (2023) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2023.01.011 · Cited by 5
Whatl’s new in diagnostics? Fungitell®: 1,3 beta-D Glucan assay
Budhavari, S. (2009) · Southern African Journal of Epidemiology and Infection · doi:10.1080/10158782.2009.11441337 · Cited by 5
Fungal infections and their treatment in the intensive care unit
Sarosi, G. A. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.ccx.0000244128.92612.50 · Cited by 5
Burghi, G., Lemiale, V., Bagnulo, H., Bódega, E., & Azoulay, É. (2010) · Medicina Intensiva · doi:10.1016/j.medin.2009.11.010 · Cited by 5
Stoneham, A. C. S., Stoneham, S., Wyllie, S. A., & Pandya, A. N. (2017) · BMJ Case Reports · doi:10.1136/bcr-2016-217923 · Cited by 7
Galactomannan and advances in fungal diagnostics
Zaas, A. K., & Alexander, B. D. (2005) · Current Opinion in Organ Transplantation · doi:10.1097/01.mot.0000187102.18780.b0 · Cited by 5
Self-citationGeneral Approaches for Direct Detection of Fungi
M.S., Y. R. S. (2011) · Wiley eBooks · doi:10.1128/9781555816728.ch114 · Cited by 5
Current evidence for the treatment of invasive fungal infections in immunocompromised patients
Auberger, J., & Lass‐Flörl, C. (2011) · Clinical Investigation · doi:10.4155/cli.11.5 · Cited by 4
Zaragoza, R., Llinares, P., Maseda, E., Ferrer, R., & Rodríguez, A. H. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.005 · Cited by 4
Úbeda, A., Vázquez, A. L., & Gil, C. L. (2010) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(10)70029-x · Cited by 4
Management of invasive fungal infections in the pediatric intensive care unit
Fisher, B. T., Zaoutis, T. E., & Chiotos, K. (2015) · Journal of Pediatric Intensive Care · doi:10.3233/pic-14108 · Cited by 4
Spriet, I., Desmet, S., Willems, L., & Lagrou, K. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01922.x · Cited by 4
Buchheidt, D. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.7.753 · Cited by 4
“Another serological test system, detecting (1 → 3)β - d -Glucan (BG), shows high positive predictive values when invasive fungal infection is caused by Aspergillus , Candida or Fusarium species, but the detection in clinical samples is not species specific, compromising an exact diagnosis of the pathogen [15] .”
BackgroundMajeed, A., Ullah, W., Zahid, U., & Mohajer, M. A. (2016) · BMJ Case Reports · doi:10.1136/bcr-2016-216979 · Cited by 4
Diagnostics: The Role of the Laboratory
Afzal, A., Kaplan, H. M., Motazedi, T., Qureshi, T. M., & Woc-Colburn, L. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-33803-9_4 · Cited by 4
Saullo, J. H., & Alexander, B. D. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00038-5 · Cited by 5
Self-citationRole of Antifungal Therapy in Complicated Intra-abdominal Infections
Bassetti, M., Vena, A., Pincino, R., Briano, F., & Giacobbe, D. R. (2020) · Current Infectious Disease Reports · doi:10.1007/s11908-020-00731-0 · Cited by 4
Song, J., Kim, S., Park, J., Park, Y., & Kim, H.-S. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115415 · Cited by 5
Molecular Diagnosis of Invasive Aspergillosis
Reyes-Montes, M. D. R., Duarte-Escalante, E., León, M. G. F.-D., Martínez-Herrera, E. O., & Acosta‐Altamirano, G. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.78694 · Cited by 4
Patterson, T. F. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00259-9 · Cited by 8
Sobel, J. D. (2006) · Infectious Diseases in Clinical Practice · doi:10.1097/01.idc.0000224556.99296.74 · Cited by 4
InvasiveCandidainfections in solid organ transplant recipient children
Şensoy, G., & Belet, N. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.6 · Cited by 4
Opportunistic and systemic fungi
Mitchell, T. G., Verweij, P. E., & Hoepelman, A. I. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00178-7 · Cited by 4
Boucher, H. W., & Patterson, T. F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-325-7_9 · Cited by 4
Invasive candidiasis in the ICU: Prophylaxis versus preemptive treatment
Rotstein, C. (2008) · Current Infectious Disease Reports · doi:10.1007/s11908-008-0074-z · Cited by 5
Behlau, I. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50345-3 · Cited by 4
Petti, C. A., Hassan, H., & Reller, L. B. (2008) · Wiley eBooks · doi:10.1128/9781555815455.ch19 · Cited by 4
Evolution in the Management of Invasive Fungal Infections in Liver Transplant Recipients
Verma, A., Weigel, K., Dexter, S. Y. K., & Dhawan, A. (2018) · OBM Transplantation · doi:10.21926/obm.transplant.1802009 · Cited by 3
Keck, J. M., Cretella, D. A., Stover, K. R., Wagner, J. L., Barber, K. E., Jhaveri, T. A., Vijayvargiya, P., Garrigos, Z. E., & Wingler, M. J. B. (2023) · Antibiotics · doi:10.3390/antibiotics12020193 · Cited by 4
Progress on nonculture based diagnostic tests for invasive mould infection
White, P. L. (2024) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000001060 · Cited by 3
Metadata
- Authors
- Ostrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., Finkelman, M. A., & Rex, J. H.
- Affiliations
- Duke University (US)
- University of Miami (US)
- University of Alabama at Birmingham (US)
- Seikagaku Corporation (Japan) (JP)
- University of Florida Health (US)
- College of Idaho (US)
- AstraZeneca (United Kingdom) (GB)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 41
- Issue
- 5
- Pages
- 654-659
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2127508258
- Cited by
- 669
- References
- 26
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 12 · 2023: 14 · 2022: 7 · 2021: 15 · 2020: 16 · 2019: 25 · 2018: 25 · 2017: 21 · 2016: 38 · 2015: 29 · 2014: 50 · 2013: 42 · 2012: 39
- FWCI
- 29.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- β-1,3-glucan, invasive fungal infections, fungal infection diagnosis, candidiasis, aspergillosis, Fusarium, Mucor, Rhizopus, Cryptococcus, antifungal therapy, sensitivity and specificity, cut-off values, interlaboratory agreement, serum biomarkers, EORTC/MSG criteria
- MeSH terms
- Adult, Aged, Female, Humans, Male, Middle Aged, Mycoses, Proteoglycans, Sensitivity and Specificity, Reproducibility of Results, beta-Glucans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.